https://www.selleckchem.com/pr....oducts/valproic-acid
This second stage of analysis resulted in the development of new tools and checklist items. CONCLUSIONS The two-stage FMEA approach successfully directed the transition to the Flexitron system by identifying the necessary changes in the checklists and workflows for all applicators utilized in our clinic. It also led to the decision to use a two-phase commissioning approach. This allowed for minimization clinical downtime, avoidance of an extra source change, and facilitation of efficient staff training. Additionally, multiple proj